key: cord-0999082-l2dr9a3y
authors: Hara, Seth A.; Rossman, Timothy L.; Johnson, Lukas; Hogan, Christopher J.; Sanchez, William; Martin, David P.; Wehde, Mark B.
title: Evidence-based Aerosol Clearance Times in a Healthcare Environment
date: 2021-08-14
journal: Infect Prev Pract
DOI: 10.1016/j.infpip.2021.100170
sha: 5046efb9c4e6544b00e37e70a8c60ffc9f3d5fa0
doc_id: 999082
cord_uid: l2dr9a3y

BACKGROUND: As researchers race to understand the nature of COVID-19 transmission, healthcare institutions must treat COVID-19 patients while also safeguarding the health of staff and other patients. One aspect of this process involves mitigating aerosol transmission of the SARS-CoV2 virus. The U.S. Centers for Disease Control and Prevention (CDC) provides general guidance on airborne contaminant removal, but directly measuring aerosol clearance in clinical rooms provides empirical evidence to guide clinical procedure. AIM: We present a risk-assessment approach to empirically measuring and certifying the aerosol clearance time (ACT) in operating and procedure rooms to improve hospital efficiency while also mitigating the risk of nosocomial infection. METHODS: Rooms were clustered based on physical and procedural parameters. Sample rooms from each cluster were randomly selected and tested by challenging the room with aerosol and monitoring aerosolized particle concentration until 99.9% clearance was achieved. Data quality was analysed and aerosol clearance times for each cluster were determined. FINDINGS: Of the 521 operating and procedure rooms considered, 449 (86%) were issued a decrease in clearance time relative to CDC guidance, 32 (6%) had their clearance times increased, and 40 (8%) remained at guidance. The average clearance time change of all rooms assessed was a net reduction of 27.8%. CONCLUSION: The process described here balances the need for high-quality, repeatable data with the burden of testing in a functioning clinical setting. Implementation of this approach resulted in a reduction in clearance times for most clinical rooms, thereby improving hospital efficiency while also safeguarding patients and staff.

Background 3

As researchers race to understand the nature of COVID-19 transmission, healthcare institutions must 4 treat COVID-19 patients while also safeguarding the health of staff and other patients. One aspect of this 5 process involves mitigating aerosol transmission of the SARS-CoV2 virus. The U.S. Centers for Disease 6

Control and Prevention (CDC) provides general guidance on airborne contaminant removal, but directly 7 measuring aerosol clearance in clinical rooms provides empirical evidence to guide clinical procedure. 8

Aim 9

We present a risk-assessment approach to empirically measuring and certifying the aerosol clearance 10 time (ACT) in operating and procedure rooms to improve hospital efficiency while also mitigating the 11 risk of nosocomial infection. 12

Rooms were clustered based on physical and procedural parameters. Sample rooms from each cluster 14

were randomly selected and tested by challenging the room with aerosol and monitoring aerosolized 15 particle concentration until 99.9% clearance was achieved. Data quality was analysed and aerosol 16 clearance times for each cluster were determined. 17

Findings 18

Of the 521 operating and procedure rooms considered, 449 (86%) were issued a decrease in clearance 19 time relative to CDC guidance, 32 (6%) had their clearance times increased, and 40 (8%) remained at 20 guidance. The average clearance time change of all rooms assessed was a net reduction of 27.8%. 21

Introduction 27 The COVID-19 pandemic has strained the staffing and facilities resources of healthcare systems around 28 the world. As researchers race to understand the nature of the disease and how it is transmitted, 29

healthcare institutions must work with the knowledge at hand to treat COVID-19 patients while also 30 safeguarding the health of staff and other patients. One aspect of this process involves mitigating 31 aerosol transmission of the SARS-CoV2 virus. 32

The mechanism of transmission for the SARS-CoV2 virus is actively under investigation and aerosol 33 transmission is a serious concern for nosocomial infection [1] [2] [3] [4] [5] . For that reason, known COVID-19 34 patients are often placed in airborne infection isolation rooms (AIIR), if available, to limit exposure to 1 others[6]. However, there is also a risk of transmission from unconfirmed COVID-19 cases, especially 2 when potentially aerosol generating procedures (AGP) are performed[7] a . While recently there has been 3 increased interest in better quantifying aerosol production in "aerosol generating procedures," 4 commonly the phrase refers to clinical procedures that potentially increase the risk of aerosolizing 5 infectious particles [8] [9] [10] . When these procedures are performed, the aerosolized infectious particles 6 that are generated must be removed from the room to prevent aerosol transmission of the virus. 7

As healthcare institutions seek to identify best practices, guidance on airborne contaminant (in this case, 8 aerosolized infectious particles) removal is provided by the U.S. Centers for Disease Control and 9

Prevention (CDC) in the form of timetables based on air exchange rate [6] . Hospital administrators can 10 use these tables and the air exchange rate for a particular room to determine policy regarding when 11 staff can enter said room without adhering to transmission-based precautions[11] and when the next 12 patient can be roomed. In this way, policy can be created from a risk-assessment approach to balance 13 infection control with patient needs. As the reality of the COVID-19 pandemic became clear, healthcare 14 administrators relied heavily on this CDC guidance to implement infection control policies. 15

The time required to remove infectious aerosol particles from a room presents competing challenges 16 regarding: (1) allowing adequate clearance time to ensure the safety of patients and staff and (2) 17 reducing room downtime to improve hospital efficiency and patient care. As such, there is a strong 18 motivation to use the most accurate and reliable information possible to balance these competing 19 needs and ensure that enough time is allowed to provide a safe environment while also efficiently 20

allocating the scarce resource of procedure and operating rooms for patient care. 21

The times provided by the CDC guideline tables are based on a single parameter-air exchange rate-22

whereas aerosol clearance is a complex, multi-factor phenomenon where aerosol particles may clear the 23 air through settling and deposition in addition to ventilation [12] [13] [14] . As such, directly measuring aerosol 24 clearance in operating and procedure rooms provides empirical evidence for the time required to 25 reduce aerosols from a room. In this work, we present a risk-assessment approach to measuring and 26 certifying the aerosol clearance time (ACT) in operating and procedure rooms to improve hospital 27 efficiency while also mitigating the risk of nosocomial infection. 28

Room identification and clustering 30 Given that Mayo Clinic's Rochester campus has several thousand procedure and operating rooms where 31 airborne transmission may be a concern, testing each individual room was deemed impractical and 32 overly burdensome for the clinical setting. Testing was prioritized for areas conducting the most high-33 risk procedures with high patient volumes. To efficiently canvas these rooms for testing, grouping was 34 performed using clinical and facility-based shared characteristics (Figure 1 ). From a clinical perspective, 35 the various types of AGP were ranked according to relative risk (Supplemental Material, Figure 1 ). This 1 was done in collaboration between specialists in infectious diseases, surgeons, and anaesthesiologists, 2 based on the probability of aerosol generation as well as the underlying probability of contagion of the 3 patient based on testing and symptoms. Clinical departments were then surveyed and rated each of 4 their rooms according to the ranking system. The rooms rated medium or high risk began using the CDC 5 guidelines to determine aerosol clearance times for all AGP occurrences and were also grouped by 6 building and department in preparation for ACT testing. In this way, rooms served by the same types of 7 air handling units and with similar equipment, layout, and furnishings would be grouped together. 8 Finally, heating, ventilation, and air conditioning (HVAC) characteristics further clustered rooms to those 9 whose and air changes per hour (ACH) were within 15%. Each cluster had one room scheduled to have 10 three unique clearance tests conducted and another a single clearance test conducted. This approach 11 minimized clinical disruption with the full test providing confidence in repeatability within a room and 12 the spot test giving assurance the clustering was performed properly. 13 

Test procedure 16 Aerosol concentration was measured with TSI® condensation particle counters (CPC, models 8525 and 17 3007, ±15% measurement uncertainty), chosen for their portability and capability to detect a range of 18 particle sizes (0.01 to >1.0 um). Although virus-containing bioaerosols also contain larger particles (0.2-1 100 µm), it was critical to capture particles in this range since they are known to be generated through 2 normal respiratory processes at high concentrations and are more likely to remain suspended in an 3 aerosol than larger particles[3,6,15]. To generate non-toxic polydisperse aerosols that mimic 4 bioaerosols, a 2% (by weight) sodium chloride solution was dispersed into the air with one or two 5 consumer-grade ultrasonic humidifiers (number depending on room size and airflow). These aerosol 6 generators dispersed large amounts of aerosol particles (1.00 µm geometric mean, 1.38 µm geometric 7 standard deviation) in short periods of time, allowing initial particle concentrations to be reached even 8

in high air exchanges per hour (ACH) rooms. 9

The field tests were performed by initially visually surveying the room for clinical use and air 10 supply/return points to determine the generator and CPC placement. HVAC systems were held at 11 steady-state and at their minimum airflow settings in order to evaluate the worst-case scenario for 12 aerosol removal. The aerosol generators were placed where the AGP source would occur (typically a bed 13 or chair). Two CPCs were co-located and positioned along a line equidistant between the generator and 14

an air return grille (Supplementary Material, Figure 2 ). Multiple CPCs allowed for detection of 15 instrument problems in real-time, minimizing further clinical disruption from retesting. Each CPC first 16 measured the background particle count present in the circulating air. The count was recorded and 17 later used to baseline the particle counts measured during the clearance test (i.e. background counts 18

were subtracted when determining clearance times). While background concentrations varied from 19 room to room, they were typically of the order 10 2 particles per cm 3 . Testing began by operating the 20 aerosol generators until the room reached a particle count of ~10,000 particles per cm 3 . The generators 21

were then stopped and the peak concentration was noted. Concentrations were recorded every 60 22 seconds until 99.9% of the peak particle concentration was removed from the room air (see 23

Supplementary Materials for example calculation). Particle concentration was recorded until 99.9% 24 clearance was directly measured, as opposed to determining the clearance rate with a subset of data 25 points and extrapolating clearance time using linear regression on the log-transform of those points. 26

While the latter is a conventional approach to determination of air change rate, this method was 27 selected to account for any transients or irregularities that may occur during testing and ensure that 28 true clearance was directly observed. For the duration of the clearance time, personnel movement in 29 the room was minimal and all entryways were closed. Whenever possible throughout testing, the room 30 air supply flow rates were verified and continuously monitored in the HVAC control system. 31 For each room cluster, the test runs from the full test room and spot test room were inspected to 4 ensure consistent decay rates visually when graphed on a semi-log chart, otherwise the room(s) were 5 re-tested. If deemed consistent, the average ACT from the full test room was compared to the spot test 6

ACT. Provided the variation of the clearance times was within 15%, the longer of the two ACTs was 7 selected for the room cluster, thereby providing the more conservative ACT for the cluster. If the 8 variation was larger, the HVAC conditions in the tested rooms were verified (i.e., supply/return airflows 9 checked and/or room clustering was reviewed). If HVAC conditions were correct, another spot test 10 room was added to the cluster to confirm cluster ACT. If unacceptable variation still remained that 11

could not be explained solely from HVAC differences, additional action was undertaken on a case-by-12

case basis, such as retesting all rooms in the cluster or further breaking the cluster into smaller clusters 13 having acceptable variation. This verification step helped ensure that the clustering and sampling 14 process properly captured the characteristic behaviour of the rooms within the cluster. Once the test 15 data were verified, they were compared to the ACT recommended by the CDC guidelines. If the 16 measured ACT was within 15% of the CDC guidance-based ACT, no change was implemented. If the 17 measured ACT was less than the CDC guidance-based ACT by 15% or more, the certified ACT was 18 reduced. If it was instead greater than the CDC guidance-based ACT by 15% or more, the certified ACT 19 was increased. Certified times were communicated with clinical leadership and informed clinical policy 20

decisions. Occasionally, rooms were certified to longer ACTs than were measured to simplify clinical 21 operations and reduce confusion amongst staff by aligning with nearby rooms measured with longer 22

ACTs. 23 J o u r n a l P r e -p r o o f

Within the Mayo Clinic -Rochester campus, over 560 operating and procedure rooms were identified by 2 clinical staff as high risk for AGPs, and over 160 of those were tested to determine their ACT. These 3 rooms were grouped into 113 clusters, as described above, with 1-44 rooms in each cluster. The test 4 process provided empirical evidence for the certification of ACTs of high risk AGP rooms across the 5

Clinic. 6

Approximately 77% of the rooms tested showed the opportunity to reduce clearance times an average 7 of 38%. Of the remaining rooms, 15% showed ACTs that were comparable to the CDC-recommended 8 guidelines and 8% of the rooms required longer times to achieve the target clearance. The measured 9

ACT distribution shifted dramatically lower (Figure 3) , with 31% of the rooms clearing 99.9% of aerosols 10 in 19 minutes or less and 67% clearing in 29 minutes or less (compared with only 7% and 40% of rooms, 11 respectively, when using CDC guidance). 12 14 Based on the test results, a total of 521 operating and procedure rooms were considered for revised 15 clearance times (excluding the room clusters where mitigation measures were implemented). Of these, 16 449 rooms (86%) were issued a decrease in ACT relative to CDC guidance, 32 (6%) had their ACTs 17 increased, and 40 rooms (8%) remained at guidance. The average ACT change of all rooms assessed was 18 a net reduction of 27.8%. Generally, the largest clearance time reductions came in rooms with the 1 longest CDC guidance-based ACTs (Figure 4) , with the ≥60 minutes group experiencing an average 2 reduction of 44%. In contrast, the room groups with CDC guidance-based ACTs from 10-19 minutes and 3 20-29 minutes experienced the least benefit from direct measurement of ACT (18% reduction). As a result of this testing, a total of 6,494 minutes was reduced from the aggregate clearance time of 7 521 operating and procedure rooms, an overall reduction of 33%. These reductions benefited clinic 8 operations in multiple ways over the course of the pandemic and the heightened precautions for 9 aerosolized infectious particles. For example, with reduced ACTs, staff could clean and prepare rooms 10 for subsequent patients sooner and without using valuable personal protective equipment (PPE). These 11 measures complemented risk-mitigation measures, such as mandatory masking on campus, and 12

contributed to Mayo Clinic's ability to serve more than 1. In addition to the data gathered supporting decreases in ACTs for most operating and procedure rooms, 6 some unexpected benefits from this process arose. As detailed above, 6% of the rooms evaluated (32 7 rooms) were certified at a longer ACT compared to the time indicated by CDC guidance. Of those 32 8 rooms, 11 were issued an increase in ACT for administrative purposes, as discussed earlier. Excluding  9 those rooms, 4% of rooms evaluated demonstrated a need for an increased ACT. This indicated that the 10 procedure outlined here captured instances where the generalized CDC guidance was not sufficient and 11 clinical policy could be adjusted accordingly to ensure staff and patient safety. That is not to say that the 12 CDC guidance itself is not worthwhile. On the contrary, the data suggest it is solid guidance. The ACT 13 recommended by the CDC guidance was greater than or equal to the measured ACT 96% of the time, 14 thereby providing a safe clinical environment for patients and staff. 15

Furthermore, this testing highlighted differences between certain HVAC system designs and 16

components, which will be considered in future construction projects. For example, it was observed that 17 ducted return air systems generally performed better than plenum return air systems, filtration levels 18

that are typically applied in fan coil units were found to underperform compared to centralized air 19

handling systems, and displacement ventilation systems generally did not meet expected clearance 20 times. Perhaps the most generalizable learning in this area was that airflow balancing to ensure accurate 21 return airflow was critical to minimize ACT variation within room clusters. Many of the rooms that were 22

found to need an increase in ACT compared to the CDC guidance-based time were found to have at least 23 one of these characteristics. 24 HVAC remediation strategies 25 Rooms that were found to have inadequate ACTs (e.g., rooms found to have ACTs longer than CDC 26 clearance times) were addressed with various HVAC remediation strategies. In areas where there was 27 additional capacity in the existing infrastructure, the air flow was increased to successfully improve 28 clearance. Occasionally, filters in fan coil units could be replaced with filters with higher minimum 29 efficiency reporting value (MERV) ratings to adequately improve ACT. However, many environments did 30 not have infrastructure that allowed for these sorts of minor modifications. In those instances, portable 31 recirculating high efficiency particulate air (HEPA) filter units were often successfully employed to 32 reduce clearance times. Although effective, this remediation strategy is less desirable since it is an active 33 remediation and relies on clinical staff to activate the unit. While seemingly trivial, this extra step 34 introduces the possibility for human error, especially in the clinical environment where additional 35

procedures are already in place to address the risk of nosocomial infection. For situations where floor 36

space was unavailable or more permanent remediation was desired, ceiling-mounted HEPA filter units 37 were installed. 38 J o u r n a l P r e -p r o o f Discrepancy with CDC guidance 1 To comprehensively understand the discrepancy between the ACT measurements and the clearance 2 times recommended by the CDC tables, a robust analytical study must be conducted. As that was not 3 the intent and outside of the scope of the present work, only a few hypotheses are offered here. Some 4 physical phenomena that are not adequately accounted for with air exchange rate are particle 5 dispersion and deposition. Airborne particles disperse and deposit on surfaces, thereby removing them 6 from the air without being carried away by air circulation [12, 14] . This is especially true in rooms with 7 increased surface areas due to furniture and equipment, as is the case in operating and procedures 8 rooms [13] . In fact, the data collected in this work showed that rooms with lower air exchange rates 9

showed more of a reduction of ACT when compared to CDC guidance than rooms with higher air 10 exchange rates. This is consistent with particle deposition becoming a more significant factor when 11

there are longer settling times and less air movement. A second possibility is that the position of the 12 supply diffusers and return grilles created faster clearance rates for particles generated from specific 13

points. This would certainly vary room-to-room and would require detailed study of airflow patterns in 14 each room to better characterize. 15

Limitations of study 16 The primary goal of the work was to improve clinical care and safety, not to study aerosol clearance. As 17 such, compromises were made that would not have been necessary in an experimental setting. One 18 such limitation is the sample size used for each cluster. The two rooms tested for each cluster are not 19 necessarily a representative sample size. However, a risk-based decision was made to minimize the 20 clinical burden of testing while making all possible efforts to ensure the collected data was meaningful 21 and useful. 22

Another limitation was the use of two CPCs in a single location. While the two units provided 23

redundancies to account for instrument failure, this procedure did not capture any possible "dead 24

zones" in the room where aerosols may stagnate and linger. Initial testing across various room types and 25 layouts indicated that clearance throughout the rooms was comparable and the effect of "dead zones" 26 would be minimal. Therefore, to ease the burden of testing to the clinical schedule, a single test location 27 was used for this study. 28

The procedure described here attempts to capture a room's ability to clear aerosols by measuring all 29 airborne particles present in the air. The instruments cannot distinguish between particle types, but 30 respond identically to the particles emitting from the aerosol generators as they do to particles that may 31 be naturally present in the environment. Precautions were taken to minimize environmental noise 32 factors such as air quality changes near building air intakes, fluctuations in ventilation rate, or even 33 particle shedding from equipment or personnel in and around the room being tested. This proved 34 particularly challenging with positive pressure and negative pressure rooms since the source and 35

destination of particles are difficult to track with the present setup. 36

The process described here provides a risk-assessment approach to evaluating aerosol clearance times 38

for operating and procedure rooms in a healthcare environment. It was designed to balance the need for 39 J o u r n a l P r e -p r o o f high-quality, repeatable data with the burden of testing in a functioning clinical setting. Our team 1 successfully implemented this process within the Rochester campus of Mayo Clinic, testing over 160 2 operating and procedure rooms and using that data to certify over 500 rooms. The data collected provided 3 a solid foundation to reduce the aerosol clearance times of the majority of the rooms evaluated, while 4 also highlighting rooms that were not performing as expected so that any faults could be addressed. We 5 believe this process is a pathway to determining aerosol clearance times based on empirical evidence in 6 order to ensure a safe environment while also wisely allocating the scarce resource of procedure and 7

operating rooms for patient care. 8

Acknowledgements 9

This work would not have been possible without the leadership and technical guidance of Mr. Tom 10

Halvorsen. Additionally, the authors thank team members in the Division of Engineering, Division of 11

Facilities Management, clinical operations, and clinical leadership at Mayo Clinic for their contributions 12 to this work. During this study, Christopher Hogan received compensation as a consultant to Mayo 13

Clinic. 14 Declarations of interest: none. 15

Funding source 16 Funding for was provided internally by the Mayo Clinic Midwest Clinical Practice Committee. 17 

Aerosol Transmission of SARS-CoV-2? Evidence, 19 Prevention and Control

Exhaled aerosol 22 increases with COVID-19 infection, age, and obesity

Airborne Transmission of SARS-CoV-2: 25 Proceedings of a Workshop-in Brief

Airborne transmission of 28 SARS-CoV-2

Viable SARS-CoV-2 in the air of 30 a hospital room with COVID-19 patients

Guidelines for Environmental Infection Control in Health-Care Facilities: (545922006-001)

Quantifying Viral Particle 35

Aerosolization Risk During Tracheostomy Surgery and Tracheostomy Care

A quantitative evaluation of 38 aerosol generation during tracheal intubation and extubation

Are tracheal intubation and extubation aerosol-generating 41 procedures?

Aerosolisation during 1 tracheal intubation and extubation in an operating theatre setting

Guideline for Isolation Precautions: Preventing 4 Transmission of Infectious Agents in Health Care Settings

MODELING INDOOR PARTICLE DEPOSITION FROM TURBULENT FLOW 7 ONTO SMOOTH SURFACES

Effects of room furnishings and 10 air speed on particle deposition rates indoors

Particle deposition indoors: a review

Comparing Aerosol 15 Concentrations and Particle Size Distributions Generated by Singing, Speaking and Breathing 16

Comparing Aerosol Concentrations and Particle Size Distributions Generated by Singing, Speaking 17 and Breathing. Aerosol Science and Technology